In vitro chemoenzymatic and in vivo biocatalytic syntheses of new beauvericin analogues.
about
Heterologous expression and structural characterisation of a pyrazinone natural product assembly lineSound of silence: the beauvericin cluster in Fusarium fujikuroi is controlled by cluster-specific and global regulators mediated by H3K27 modification.Bacillus subtilis as heterologous host for the secretory production of the non-ribosomal cyclodepsipeptide enniatin.Cyclodepsipeptides: a rich source of biologically active compounds for drug research.Nonribosomal Peptide Synthesis-Principles and Prospects.Identifying the Minimal Enzymes Required for Biosynthesis of Epoxyketone Proteasome Inhibitors.Harnessing natural product assembly lines: structure, promiscuity, and engineering.Endophytes as producers of peptides: an overview about the recently discovered peptides from endophytic microbes.Engineering the heterologous expression of lanthipeptides in Escherichia coli by multigene assembly.Synthesis of Natural and Unnatural Cyclooligomeric Depsipeptides Enabled by Flow Chemistry.An economical and safe procedure to synthesize 2-hydroxy-4-pentynoic acid: A precursor towards 'clickable' biodegradable polylactide.Engineering of Aspergillus niger for the production of secondary metabolites.Characterization of AusA: a dimodular nonribosomal peptide synthetase responsible for the production of aureusimine pyrazinones.Scale-up bioprocess development for production of the antibiotic valinomycin in Escherichia coli based on consistent fed-batch cultivations.Harnessing fungal nonribosomal cyclodepsipeptide synthetases for mechanistic insights and tailored engineering.Reprogramming the Biosynthesis of Cyclodepsipeptide Synthetases to Obtain New Enniatins and Beauvericins.Aspergillus niger is a superior expression host for the production of bioactive fungal cyclodepsipeptides.A Self-Sacrificing N-Methyltransferase Is the Precursor of the Fungal Natural Product Omphalotin.Cell-free synthetic biology for in vitro biosynthesis of pharmaceutical natural products.Hot off the Press
P2860
Q27682818-10BD8EA1-63CE-49ED-A955-78A3C1D4B781Q30313821-DCEB8CDD-3E1D-427C-A4C2-93CB84A89B8EQ35014491-7C4FE0B0-8E93-4FD4-8D6F-D1970FE37A4DQ35231054-CC1F60DD-1AED-469B-9B52-41B76435F65EQ36316177-A4D60648-2CF0-400C-B6A1-234119FD041EQ36469865-DF6C4B20-C38A-42E7-B35B-6F3D917D4EEFQ36578763-228C044F-C576-4962-B383-3698572372DAQ38247822-831F2B02-F7C0-415F-8ED3-46EEB2501224Q39021205-0470DE5D-724B-4AAC-A145-E5E4B6501402Q39152820-A1660F68-EE25-4B52-9F69-98C5D4C88007Q41588288-3E20F884-44EF-4EA9-A361-5DF757F47A38Q41685066-ACB7CACA-D4E1-4B3D-A148-F7297DADF9C4Q42109802-3A7B28A7-B531-4448-B941-75B6E36ACBB2Q42517578-73115C03-EEFB-4648-8CC4-8FB53784CFD1Q47325243-F9CB9773-BF3A-4117-8541-4B9A30288C60Q51608114-DC8FB8E3-22F1-439B-80CF-CF7357F616C1Q52672921-28A65E86-C72C-41DB-AE38-9A0A97759196Q52837051-804052A8-648B-431D-A291-0D0115B0CAB9Q55241254-6CF2031A-43A7-4D9D-9045-0A08EFE9B171Q58856827-CE1E9097-8792-49F1-A762-7657BC49F749
P2860
In vitro chemoenzymatic and in vivo biocatalytic syntheses of new beauvericin analogues.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
In vitro chemoenzymatic and in vivo biocatalytic syntheses of new beauvericin analogues.
@en
In vitro chemoenzymatic and in vivo biocatalytic syntheses of new beauvericin analogues.
@nl
type
label
In vitro chemoenzymatic and in vivo biocatalytic syntheses of new beauvericin analogues.
@en
In vitro chemoenzymatic and in vivo biocatalytic syntheses of new beauvericin analogues.
@nl
prefLabel
In vitro chemoenzymatic and in vivo biocatalytic syntheses of new beauvericin analogues.
@en
In vitro chemoenzymatic and in vivo biocatalytic syntheses of new beauvericin analogues.
@nl
P2093
P2860
P356
P1476
In vitro chemoenzymatic and in vivo biocatalytic syntheses of new beauvericin analogues.
@en
P2093
Alexander Denisiuk
Diana Matthes
István Molnár
Jane Müller
Lennart Richter
Patricia Espinosa-Artiles
Sven C Feifel
P2860
P304
P356
10.1039/C2CC31669B
P407
P577
2012-05-01T00:00:00Z